Abstract
A long-term goal of oncogene research is to understand how proto-oncogene products affect cell physiology and how their function is subverted in their mutationally activated form. Oncogene products are widely regarded as playing a role in cell growth and control, but they may also contribute to the malignant phenotype by influencing cell functions other than growth. The effect of oncogenes on the expression of antigens of the major histocompatibility complex (MHC) is one such example. These molecules are of particular interest because both experimental (1–4) and clinical evidence (5,6) suggests their expression on cancer cells can correlate with the ability of the host to reject the tumour. The function of these molecules is integral to the process of immune recognition, and it is thought that their expression decreases the tumorigen-icity of cancer cells as a result of immunosurveillance by T cells. Modulation of MHC antigen expression by oncogenes, therefore, has a dual significance: not only may it provide information concerning the interaction of oncogenes with intracellular signalling pathways, but the outcome of this interaction may have indirect consequences for tumour growth.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
W. J. Bateman, R. Fiera, N. Matthews, A. G. Morris, Inducibility of class II major histocompatibility complex antigens by interferon-γ is associated with reduced tumorigenicity in C3H mouse fibroblasts transformed by v-Ki-ras, J. Exp. Med., 173: 193–196 (1991)
R. F. L. James, S. Edwards, K. M. Hui, P.D. Bassett, F. Grosveld, The effect of class II gene transfection on the tumorigenicity of the H-2K-negative mouse leukaemia cell line K36.16, Immunology, 72: 213–218 (1991)
S. O-Rosenberg, A. Thakur, V. Clements, Rejection of mouse sarcoma cells after transfection of MHC class II genes, J. Immunol., 144: 4068–4071 (1990)
G. J. Hammerling, D. Klar, W. Pulm, F. Momburg, G. Moldenhauer, The influence of major histocompatibility complex class I antigens on tumour growth and metastasis, Biochim. Biophys. Acta, 907:245–259 (1987)
T. P. Miller, S. M. Lippman, C. M. Spier, D. J. Slymen, T. M. Grogan, HLA-DR (Ia) antigen immune phenotype predicts outcome for patients with diffuse large cell lymphoma, J. Clin. Invest., 82: 370–372 (1988)
F. Esterban, F. Ruiz-Cabello, A. Concha, M. Perezayala, J. Sanchezrosas, F. Garrido, HLA-DR expression is associated with excellent prognosis in squamous cell carcinoma of the larynx, Clin. Exp. Metastasis, 8: 319–328 (1990)
P. Giacomini, P. B. Fisher, G. J. Duigou, R. Gambari, P. G. Natali, Regulation of class II MHC gene expression by interferons, Anticancer Research, 8: 1153–1162 (1988)
C. R. Hume, R. S. Accolla, J. S. Lee, Defective HLA class II expression in a regulatory mutant is partially complemented by activated ras oncogenes, Proc. Natl. Acad. Sci. USA, 84: 8603–8607 (1987)
A. P. Albino, A. N. Houghton, M. Eisinger, J. S. Lee, R. R. S. Kantor, A. I. Oliff, L. J. Old, Class II histocompatibility antigen expression in human melanocytes transformed by Harvey murine sarcoma virus (Ha-MSV) and Kirsten MSV retroviruses, J. Exp. Med., 164: 1710–1722 (1986)
D. J. Maudsley, A. G. Morris, Kirsten murine sarcoma virus abolishes interferon-γ-induced class II but not class I major histocompatibility antigen expression in a murine fibroblast line, J. Exp. Med., 167: 706–711 (1988)
A. Balmain, M. Ramsden, G. T. Bowden, J. Smith, Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas, Nature (Lond.), 307: 658–660 (1984)
K. Brown, M. Quintanilla, M. Ramsden, I. B. Kerr, S. Young, A. Balmain, v-ras genes from Harvey and Balb murine sarcoma viruses can act as initiators of two-stage mouse skin carcinogenesis, Cell, 46: 447–456 (1986)
E. Liu, B. Hjelle, R. Morgan, F. Hecht, J. M. Bishop, Mutations of the Kirsten-ras proto-oncogene in human preleukaemia, Nature (Lond.), 330: 186–188 (1987)
A. G. Morris, G. Ward, Production of recombinant interferons by expression in heterologous mammalian cells, in: Interferons and Lymphokines: a practical approach, M. Clemens, A. G. Morris, A. Gearing, editors. IRL Press: Oxford, 61–71 (1987)
G. J. Atkins, M. D. Johnston, L. M. Westmacott, D. C. Burke, Induction of interferon in chick cells by temperature-sensitive mutants of Sindbis virus, J. Gen. Virol., 25: 381 (1974)
M. E. F. Smith, J. G. Bodmer, A. P. Kelly, J. Trowsdale, S. C. Kirkland, W. F. Bodmer, Variation in HLA expression on tumours, in: Cold Spring Harbor Symposia on Quantitative Biology, vol. LIV Cold Spring Harbor Laboratory Press (1989)
F. Momburg, A. Ziegler, J. Harpprecht, P. Moller, G. Moldenhauer, G. J. Hammerling, Selective loss of HLA-A or HLA-B antigen expression in colon carcinoma, J. Immunol., 142: 352–358 (1989)
J. L. Bos, E. R. Fearon, S. R. Hamilton, M. Verlaan-de Vries, J. H. van Boom, A. J. van der Eb, B. Vogelstein, Prevalence of ras gene mutations in human colorectal cancers, Nature (Lond.), 327: 293–297 (1987)
M. R. Oliva, T. Cabrera, J. Esquivias, M. Perez-Ayala, M. Redondo, F. Ruiz-Cabello, F. Garrido, K-ras mutations (codon 12) are not involved in down-regulation of MHC class I genes in colon carcinomas, Int. J. Cancer, 46: 426–431 (1990)
P. L. Kaplan, M. Anderson, B. Ozanne, Transforming growth factor(s) production enables cells to grow in the absence of serum: an autocrine system, Proc. Natl. Acad. Sci. USA, 79: 485–489 (1982)
R. D. Owen, M. C. Ostrowski, Transcriptional activation of a conserved sequence element by ras requires a nuclear factor distinct from c-fos or c-jun, Proc. Natl. Acad. Sci. USA, 87: 3866–3870 (1990)
C. W. Czarniecki, H. H. Chiu, G. H. W. Wong, S. M. McCabe, M. A. Palladino, Transforming growth factor-β modulates the expression of class II histocompatibility antigens on human cells, J. Immunol., 140: 4217–4223 (1988)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Plenum Press, New York
About this chapter
Cite this chapter
Darley, R.L., Morris, A.G. (1991). The v-Ki-ras Oncogene Up-Regulates Major Histocompatibility Class II Antigen Expression in Early-Passage Fibroblasts. In: Spandidos, D.A. (eds) The Superfamily of ras-Related Genes. NATO ASI Series, vol 220. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-6018-6_15
Download citation
DOI: https://doi.org/10.1007/978-1-4684-6018-6_15
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-6020-9
Online ISBN: 978-1-4684-6018-6
eBook Packages: Springer Book Archive